...
首页> 外文期刊>Muscle and Nerve >Myasthenia gravis exacerbation after cetirizine administration.
【24h】

Myasthenia gravis exacerbation after cetirizine administration.

机译:西替利嗪给药后重症肌无力加重。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 22-year-old woman presented with a 6-month history of proximal muscle weakness, dysphagia, and weakness of jaw closure in December 1992. Neurological examination revealed nasal speech, weakness of proximal muscles of upper and lower limbs (4/5), and bilateral "Bell sign." Ptosis and diplopia were apparent after a fatigability test. The serum acetylcholine receptor binding antibody titer was elevated. Repetitive nerve stimulation at 3 Hz with recording from abductor dig-iti minimi and nasalis induced decremental responses of 18% and 31%, respectively. Chest tomography showed both enlarged and small nodular lesions without contra'st enhancement in the thymus gland. The patient had symptomatic improvement in response to treatment with pyridostigmine (60 mg every 8 h) over the next 10 days. At the time of discharge, she was asymptomatic. The thymus gland was removed 20 days later and was found to have follicular hyperplasia. This patient would be classified as IIIb according to the Myasthenia Gravis Foundation of America (MGFA) clinical classification.
机译:1992年12月,一名22岁的女性出现了近6个月的近端肌肉无力,吞咽困难和下颌闭合无力的病史。神经系统检查显示鼻部讲话,上下肢近端肌肉无力(4/5) ,以及双边的“响铃标志”。经过易疲劳性测试后,眼睑下垂和复视很明显。血清乙酰胆碱受体结合抗体滴度升高。以3 Hz的频率重复神经刺激,并记录了外展肌和鼻梁引起的递减反应,分别为18%和31%。胸部断层扫描显示,在胸腺中,既有增大的结节又有小结节性病变,而没有增强。在接下来的10天内,患者接受吡tig斯的明治疗(每8小时60 mg)的症状有所改善。出院时,她没有症状。 20天后摘除胸腺,发现其有滤泡增生。根据美国重症肌无力基金会(MGFA)的临床分类,该患者将被分类为IIIb。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号